The global Hemostatic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The world's leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.

This report aims to provide a comprehensive presentation of the global market for Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostatic Agents.

Report Scope

The Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hemostatic Agents Market Report

Report Metric	Details
Report Name	Hemostatic Agents Market
Segment by Type	Gelation Sponge Oxidized Regenerated Cellulose Based Hemostats Others
Segment by Application	Hospitals Surgical Centers Nursing Homes
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, CryoLife, BioCer Entwicklungs, Biom’Up SAS
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hemostatic Agents Market report?

Ans: The main players in the Hemostatic Agents Market are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies, Z-Medica, CryoLife, BioCer Entwicklungs, Biom’Up SAS

What are the Application segmentation covered in the Hemostatic Agents Market report?

Ans: The Applications covered in the Hemostatic Agents Market report are Hospitals, Surgical Centers, Nursing Homes

What are the Type segmentation covered in the Hemostatic Agents Market report?

Ans: The Types covered in the Hemostatic Agents Market report are Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats, Others

1 Hemostatic Agents Market Overview

1.1 Product Overview and Scope of Hemostatic Agents

1.2 Hemostatic Agents Segment by Type

1.2.1 Global Hemostatic Agents Market Value Comparison by Type (2024-2030)

1.2.2 Gelation Sponge

1.2.3 Oxidized Regenerated Cellulose Based Hemostats

1.2.4 Others

1.3 Hemostatic Agents Segment by Application

1.3.1 Global Hemostatic Agents Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Surgical Centers

1.3.4 Nursing Homes

1.4 Global Hemostatic Agents Market Size Estimates and Forecasts

1.4.1 Global Hemostatic Agents Revenue 2019-2030

1.4.2 Global Hemostatic Agents Sales 2019-2030

1.4.3 Global Hemostatic Agents Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Hemostatic Agents Market Competition by Manufacturers

2.1 Global Hemostatic Agents Sales Market Share by Manufacturers (2019-2024)

2.2 Global Hemostatic Agents Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Hemostatic Agents Average Price by Manufacturers (2019-2024)

2.4 Global Hemostatic Agents Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Hemostatic Agents, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Hemostatic Agents, Product Type & Application

2.7 Hemostatic Agents Market Competitive Situation and Trends

2.7.1 Hemostatic Agents Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Hemostatic Agents Players Market Share by Revenue

2.7.3 Global Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hemostatic Agents Retrospective Market Scenario by Region

3.1 Global Hemostatic Agents Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Hemostatic Agents Global Hemostatic Agents Sales by Region: 2019-2030

3.2.1 Global Hemostatic Agents Sales by Region: 2019-2024

3.2.2 Global Hemostatic Agents Sales by Region: 2025-2030

3.3 Global Hemostatic Agents Global Hemostatic Agents Revenue by Region: 2019-2030

3.3.1 Global Hemostatic Agents Revenue by Region: 2019-2024

3.3.2 Global Hemostatic Agents Revenue by Region: 2025-2030

3.4 North America Hemostatic Agents Market Facts & Figures by Country

3.4.1 North America Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Hemostatic Agents Sales by Country (2019-2030)

3.4.3 North America Hemostatic Agents Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Hemostatic Agents Market Facts & Figures by Country

3.5.1 Europe Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Hemostatic Agents Sales by Country (2019-2030)

3.5.3 Europe Hemostatic Agents Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Hemostatic Agents Market Facts & Figures by Country

3.6.1 Asia Pacific Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Hemostatic Agents Sales by Country (2019-2030)

3.6.3 Asia Pacific Hemostatic Agents Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Hemostatic Agents Market Facts & Figures by Country

3.7.1 Latin America Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Hemostatic Agents Sales by Country (2019-2030)

3.7.3 Latin America Hemostatic Agents Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Hemostatic Agents Market Facts & Figures by Country

3.8.1 Middle East and Africa Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Hemostatic Agents Sales by Country (2019-2030)

3.8.3 Middle East and Africa Hemostatic Agents Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Hemostatic Agents Sales by Type (2019-2030)

4.1.1 Global Hemostatic Agents Sales by Type (2019-2024)

4.1.2 Global Hemostatic Agents Sales by Type (2025-2030)

4.1.3 Global Hemostatic Agents Sales Market Share by Type (2019-2030)

4.2 Global Hemostatic Agents Revenue by Type (2019-2030)

4.2.1 Global Hemostatic Agents Revenue by Type (2019-2024)

4.2.2 Global Hemostatic Agents Revenue by Type (2025-2030)

4.2.3 Global Hemostatic Agents Revenue Market Share by Type (2019-2030)

4.3 Global Hemostatic Agents Price by Type (2019-2030)

5 Segment by Application

5.1 Global Hemostatic Agents Sales by Application (2019-2030)

5.1.1 Global Hemostatic Agents Sales by Application (2019-2024)

5.1.2 Global Hemostatic Agents Sales by Application (2025-2030)

5.1.3 Global Hemostatic Agents Sales Market Share by Application (2019-2030)

5.2 Global Hemostatic Agents Revenue by Application (2019-2030)

5.2.1 Global Hemostatic Agents Revenue by Application (2019-2024)

5.2.2 Global Hemostatic Agents Revenue by Application (2025-2030)

5.2.3 Global Hemostatic Agents Revenue Market Share by Application (2019-2030)

5.3 Global Hemostatic Agents Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Ethicon

6.1.1 Ethicon Corporation Information

6.1.2 Ethicon Description and Business Overview

6.1.3 Ethicon Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Ethicon Hemostatic Agents Product Portfolio

6.1.5 Ethicon Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Corporation Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Pfizer Hemostatic Agents Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Baxter International

6.3.1 Baxter International Corporation Information

6.3.2 Baxter International Description and Business Overview

6.3.3 Baxter International Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Baxter International Hemostatic Agents Product Portfolio

6.3.5 Baxter International Recent Developments/Updates

6.4 C. R. Bard

6.4.1 C. R. Bard Corporation Information

6.4.2 C. R. Bard Description and Business Overview

6.4.3 C. R. Bard Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.4.4 C. R. Bard Hemostatic Agents Product Portfolio

6.4.5 C. R. Bard Recent Developments/Updates

6.5 The Medicines Company

6.5.1 The Medicines Company Corporation Information

6.5.2 The Medicines Company Description and Business Overview

6.5.3 The Medicines Company Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.5.4 The Medicines Company Hemostatic Agents Product Portfolio

6.5.5 The Medicines Company Recent Developments/Updates

6.6 Anika Therapeutics

6.6.1 Anika Therapeutics Corporation Information

6.6.2 Anika Therapeutics Description and Business Overview

6.6.3 Anika Therapeutics Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Anika Therapeutics Hemostatic Agents Product Portfolio

6.6.5 Anika Therapeutics Recent Developments/Updates

6.7 Advanced Medical Solutions

6.6.1 Advanced Medical Solutions Corporation Information

6.6.2 Advanced Medical Solutions Description and Business Overview

6.6.3 Advanced Medical Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Advanced Medical Solutions Hemostatic Agents Product Portfolio

6.7.5 Advanced Medical Solutions Recent Developments/Updates

6.8 Integra LifeSciences

6.8.1 Integra LifeSciences Corporation Information

6.8.2 Integra LifeSciences Description and Business Overview

6.8.3 Integra LifeSciences Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Integra LifeSciences Hemostatic Agents Product Portfolio

6.8.5 Integra LifeSciences Recent Developments/Updates

6.9 B Braun Melsungen

6.9.1 B Braun Melsungen Corporation Information

6.9.2 B Braun Melsungen Description and Business Overview

6.9.3 B Braun Melsungen Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.9.4 B Braun Melsungen Hemostatic Agents Product Portfolio

6.9.5 B Braun Melsungen Recent Developments/Updates

6.10 Gelita Medical

6.10.1 Gelita Medical Corporation Information

6.10.2 Gelita Medical Description and Business Overview

6.10.3 Gelita Medical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Gelita Medical Hemostatic Agents Product Portfolio

6.10.5 Gelita Medical Recent Developments/Updates

6.11 Equimedical

6.11.1 Equimedical Corporation Information

6.11.2 Equimedical Hemostatic Agents Description and Business Overview

6.11.3 Equimedical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Equimedical Hemostatic Agents Product Portfolio

6.11.5 Equimedical Recent Developments/Updates

6.12 Vascular Solutions

6.12.1 Vascular Solutions Corporation Information

6.12.2 Vascular Solutions Hemostatic Agents Description and Business Overview

6.12.3 Vascular Solutions Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Vascular Solutions Hemostatic Agents Product Portfolio

6.12.5 Vascular Solutions Recent Developments/Updates

6.13 Marine Polymer Technologies

6.13.1 Marine Polymer Technologies Corporation Information

6.13.2 Marine Polymer Technologies Hemostatic Agents Description and Business Overview

6.13.3 Marine Polymer Technologies Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Marine Polymer Technologies Hemostatic Agents Product Portfolio

6.13.5 Marine Polymer Technologies Recent Developments/Updates

6.14 Z-Medica

6.14.1 Z-Medica Corporation Information

6.14.2 Z-Medica Hemostatic Agents Description and Business Overview

6.14.3 Z-Medica Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Z-Medica Hemostatic Agents Product Portfolio

6.14.5 Z-Medica Recent Developments/Updates

6.15 CryoLife

6.15.1 CryoLife Corporation Information

6.15.2 CryoLife Hemostatic Agents Description and Business Overview

6.15.3 CryoLife Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.15.4 CryoLife Hemostatic Agents Product Portfolio

6.15.5 CryoLife Recent Developments/Updates

6.16 BioCer Entwicklungs

6.16.1 BioCer Entwicklungs Corporation Information

6.16.2 BioCer Entwicklungs Hemostatic Agents Description and Business Overview

6.16.3 BioCer Entwicklungs Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.16.4 BioCer Entwicklungs Hemostatic Agents Product Portfolio

6.16.5 BioCer Entwicklungs Recent Developments/Updates

6.17 Biom’Up SAS

6.17.1 Biom’Up SAS Corporation Information

6.17.2 Biom’Up SAS Hemostatic Agents Description and Business Overview

6.17.3 Biom’Up SAS Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)

6.17.4 Biom’Up SAS Hemostatic Agents Product Portfolio

6.17.5 Biom’Up SAS Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Hemostatic Agents Industry Chain Analysis

7.2 Hemostatic Agents Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Hemostatic Agents Production Mode & Process

7.4 Hemostatic Agents Sales and Marketing

7.4.1 Hemostatic Agents Sales Channels

7.4.2 Hemostatic Agents Distributors

7.5 Hemostatic Agents Customers

8 Hemostatic Agents Market Dynamics

8.1 Hemostatic Agents Industry Trends

8.2 Hemostatic Agents Market Drivers

8.3 Hemostatic Agents Market Challenges

8.4 Hemostatic Agents Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

The Medicines Company

Anika Therapeutics

Advanced Medical Solutions

Marine Polymer Technologies

Z-Medica

BioCer Entwicklungs

Biom'Up SAS

List of Tables

Table 1. Global Hemostatic Agents Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Hemostatic Agents Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Hemostatic Agents Market Competitive Situation by Manufacturers in 2023

Table 4. Global Hemostatic Agents Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Hemostatic Agents Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Hemostatic Agents Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Hemostatic Agents Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Hemostatic Agents Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Hemostatic Agents, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Hemostatic Agents, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Hemostatic Agents, Product Type & Application

Table 12. Global Key Manufacturers of Hemostatic Agents, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostatic Agents as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Hemostatic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Hemostatic Agents Sales by Region (2019-2024) & (K Units)

Table 18. Global Hemostatic Agents Sales Market Share by Region (2019-2024)

Table 19. Global Hemostatic Agents Sales by Region (2025-2030) & (K Units)

Table 20. Global Hemostatic Agents Sales Market Share by Region (2025-2030)

Table 21. Global Hemostatic Agents Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Hemostatic Agents Revenue Market Share by Region (2019-2024)

Table 23. Global Hemostatic Agents Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Hemostatic Agents Revenue Market Share by Region (2025-2030)

Table 25. North America Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Hemostatic Agents Sales by Country (2019-2024) & (K Units)

Table 27. North America Hemostatic Agents Sales by Country (2025-2030) & (K Units)

Table 28. North America Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Hemostatic Agents Sales by Country (2019-2024) & (K Units)

Table 32. Europe Hemostatic Agents Sales by Country (2025-2030) & (K Units)

Table 33. Europe Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Hemostatic Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Hemostatic Agents Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Hemostatic Agents Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Hemostatic Agents Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Hemostatic Agents Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Hemostatic Agents Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Hemostatic Agents Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Hemostatic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Hemostatic Agents Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Hemostatic Agents Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Hemostatic Agents Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Hemostatic Agents Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Hemostatic Agents Sales (K Units) by Type (2019-2024)

Table 51. Global Hemostatic Agents Sales (K Units) by Type (2025-2030)

Table 52. Global Hemostatic Agents Sales Market Share by Type (2019-2024)

Table 53. Global Hemostatic Agents Sales Market Share by Type (2025-2030)

Table 54. Global Hemostatic Agents Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Hemostatic Agents Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Hemostatic Agents Revenue Market Share by Type (2019-2024)

Table 57. Global Hemostatic Agents Revenue Market Share by Type (2025-2030)

Table 58. Global Hemostatic Agents Price (USD/Unit) by Type (2019-2024)

Table 59. Global Hemostatic Agents Price (USD/Unit) by Type (2025-2030)

Table 60. Global Hemostatic Agents Sales (K Units) by Application (2019-2024)

Table 61. Global Hemostatic Agents Sales (K Units) by Application (2025-2030)

Table 62. Global Hemostatic Agents Sales Market Share by Application (2019-2024)

Table 63. Global Hemostatic Agents Sales Market Share by Application (2025-2030)

Table 64. Global Hemostatic Agents Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Hemostatic Agents Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Hemostatic Agents Revenue Market Share by Application (2019-2024)

Table 67. Global Hemostatic Agents Revenue Market Share by Application (2025-2030)

Table 68. Global Hemostatic Agents Price (USD/Unit) by Application (2019-2024)

Table 69. Global Hemostatic Agents Price (USD/Unit) by Application (2025-2030)

Table 70. Ethicon Corporation Information

Table 71. Ethicon Description and Business Overview

Table 72. Ethicon Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Ethicon Hemostatic Agents Product

Table 74. Ethicon Recent Developments/Updates

Table 75. Pfizer Corporation Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Pfizer Hemostatic Agents Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Baxter International Corporation Information

Table 81. Baxter International Description and Business Overview

Table 82. Baxter International Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Baxter International Hemostatic Agents Product

Table 84. Baxter International Recent Developments/Updates

Table 85. C. R. Bard Corporation Information

Table 86. C. R. Bard Description and Business Overview

Table 87. C. R. Bard Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. C. R. Bard Hemostatic Agents Product

Table 89. C. R. Bard Recent Developments/Updates

Table 90. The Medicines Company Corporation Information

Table 91. The Medicines Company Description and Business Overview

Table 92. The Medicines Company Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. The Medicines Company Hemostatic Agents Product

Table 94. The Medicines Company Recent Developments/Updates

Table 95. Anika Therapeutics Corporation Information

Table 96. Anika Therapeutics Description and Business Overview

Table 97. Anika Therapeutics Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Anika Therapeutics Hemostatic Agents Product

Table 99. Anika Therapeutics Recent Developments/Updates

Table 100. Advanced Medical Solutions Corporation Information

Table 101. Advanced Medical Solutions Description and Business Overview

Table 102. Advanced Medical Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Advanced Medical Solutions Hemostatic Agents Product

Table 104. Advanced Medical Solutions Recent Developments/Updates

Table 105. Integra LifeSciences Corporation Information

Table 106. Integra LifeSciences Description and Business Overview

Table 107. Integra LifeSciences Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Integra LifeSciences Hemostatic Agents Product

Table 109. Integra LifeSciences Recent Developments/Updates

Table 110. B Braun Melsungen Corporation Information

Table 111. B Braun Melsungen Description and Business Overview

Table 112. B Braun Melsungen Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. B Braun Melsungen Hemostatic Agents Product

Table 114. B Braun Melsungen Recent Developments/Updates

Table 115. Gelita Medical Corporation Information

Table 116. Gelita Medical Description and Business Overview

Table 117. Gelita Medical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Gelita Medical Hemostatic Agents Product

Table 119. Gelita Medical Recent Developments/Updates

Table 120. Equimedical Corporation Information

Table 121. Equimedical Description and Business Overview

Table 122. Equimedical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Equimedical Hemostatic Agents Product

Table 124. Equimedical Recent Developments/Updates

Table 125. Vascular Solutions Corporation Information

Table 126. Vascular Solutions Description and Business Overview

Table 127. Vascular Solutions Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Vascular Solutions Hemostatic Agents Product

Table 129. Vascular Solutions Recent Developments/Updates

Table 130. Marine Polymer Technologies Corporation Information

Table 131. Marine Polymer Technologies Description and Business Overview

Table 132. Marine Polymer Technologies Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Marine Polymer Technologies Hemostatic Agents Product

Table 134. Marine Polymer Technologies Recent Developments/Updates

Table 135. Z-Medica Corporation Information

Table 136. Z-Medica Description and Business Overview

Table 137. Z-Medica Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Z-Medica Hemostatic Agents Product

Table 139. Z-Medica Recent Developments/Updates

Table 140. CryoLife Corporation Information

Table 141. CryoLife Description and Business Overview

Table 142. CryoLife Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 143. CryoLife Hemostatic Agents Product

Table 144. CryoLife Recent Developments/Updates

Table 145. BioCer Entwicklungs Corporation Information

Table 146. BioCer Entwicklungs Description and Business Overview

Table 147. BioCer Entwicklungs Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 148. BioCer Entwicklungs Hemostatic Agents Product

Table 149. BioCer Entwicklungs Recent Developments/Updates

Table 150. Biom’Up SAS Corporation Information

Table 151. Biom’Up SAS Description and Business Overview

Table 152. Biom’Up SAS Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 153. Biom’Up SAS Hemostatic Agents Product

Table 154. Biom’Up SAS Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Hemostatic Agents Distributors List

Table 158. Hemostatic Agents Customers List

Table 159. Hemostatic Agents Market Trends

Table 160. Hemostatic Agents Market Drivers

Table 161. Hemostatic Agents Market Challenges

Table 162. Hemostatic Agents Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Hemostatic Agents

Figure 2. Global Hemostatic Agents Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Hemostatic Agents Market Share by Type in 2023 & 2030

Figure 4. Gelation Sponge Product Picture

Figure 5. Oxidized Regenerated Cellulose Based Hemostats Product Picture

Figure 6. Others Product Picture

Figure 7. Global Hemostatic Agents Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Hemostatic Agents Market Share by Application in 2023 & 2030

Figure 9. Hospitals

Figure 10. Surgical Centers

Figure 11. Nursing Homes

Figure 12. Global Hemostatic Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Hemostatic Agents Market Size (2019-2030) & (US$ Million)

Figure 14. Global Hemostatic Agents Sales (2019-2030) & (K Units)

Figure 15. Global Hemostatic Agents Average Price (USD/Unit) & (2019-2030)

Figure 16. Hemostatic Agents Report Years Considered

Figure 17. Hemostatic Agents Sales Share by Manufacturers in 2023

Figure 18. Global Hemostatic Agents Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Hemostatic Agents Players: Market Share by Revenue in 2023

Figure 20. Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Hemostatic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Hemostatic Agents Sales Market Share by Country (2019-2030)

Figure 23. North America Hemostatic Agents Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Hemostatic Agents Sales Market Share by Country (2019-2030)

Figure 27. Europe Hemostatic Agents Revenue Market Share by Country (2019-2030)

Figure 28. Germany Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Hemostatic Agents Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Hemostatic Agents Revenue Market Share by Region (2019-2030)

Figure 35. China Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Hemostatic Agents Sales Market Share by Country (2019-2030)

Figure 46. Latin America Hemostatic Agents Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Hemostatic Agents Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Hemostatic Agents Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. U.A.E Hemostatic Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Hemostatic Agents by Type (2019-2030)

Figure 56. Global Revenue Market Share of Hemostatic Agents by Type (2019-2030)

Figure 57. Global Hemostatic Agents Price (USD/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Hemostatic Agents by Application (2019-2030)

Figure 59. Global Revenue Market Share of Hemostatic Agents by Application (2019-2030)

Figure 60. Global Hemostatic Agents Price (USD/Unit) by Application (2019-2030)

Figure 61. Hemostatic Agents Value Chain

Figure 62. Hemostatic Agents Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global PET Scan Devices Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-4Z8672

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Cell Expansion Disposable Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-14V8437

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Microtest Plates Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-32R8350

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Tissue Slicer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-26U3291

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions